Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...
LADA often progresses slowly, but in most people, it ultimately requires insulin treatment. If you’ve had treatments for type 2 diabetes for several years or more, a sudden change in your ...
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...
PHILADELPHIA - A Philadelphia jail caused the death of a diabetic inmate by failing to provide insulin and other medical care, according to a federal lawsuit filed by the man's family Wednesday.
About 2 million Americans with Type 1 diabetes must take the medication to regulate their blood sugar because their bodies do not produce insulin. Millions more with Type 2 diabetes also take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback